A welcome message from Jonathan A. Epstein, M.D., Executive Vice Dean and Chief Scientific Officer

Research Overview & Strategic Focus

Research Overview & Strategic Focus

As the nation’s first medical school and home to the first teaching hospital, the Perelman School of Medicine has a long tradition of academic excellence and scientific discovery.  Building on this tradition, our innovative, interdisciplinary research programs continue today to pave the way for a future of new paradigms in cutting-edge science. As an internationally renowned community of scientists and physicians, we are dedicated to both advancing knowledge and fostering a culture of excellence in training the next generation of scientific leaders. Our faculty are at the forefront of the biomedical revolution, and we are committed to sustaining a vibrant intellectual environment, with the ultimate goal of translating ground-breaking discoveries into medical therapies that will eradicate disease and improve health care around the world.

The School's research enterprise incorporates all areas of contemporary biomedical investigation, with the advantage of being unified on a single campus. The School is comprised of 28 basic and clinical departments, with over 2,700 faculty members and more than 2,500 students and trainees. In fiscal year 2019, the School received $908.2 million in support of its research activities from extramural sponsors, including $493 million from the National Institutes of Health, ranking third in the nation among all academic medical institutions.

Faculty at the Perelman School of Medicine work across disciplines to expand the frontiers of scientific knowledge while translating significant breakthroughs into tangible health benefits to improve the lives of patients.  Within its diverse, interdisciplinary network of expertise, resources, and exceptional faculty, staff and trainees, the Perelman School of Medicine epitomizes collaborative research across departments and schools, as exemplified by our 30 centers and institutes.  These include the Abramson Cancer Center, one of 49 Comprehensive Cancer Centers in the country approved and designated by the National Cancer Institute. The Penn Cardiovascular Institute,  the Penn Center for AIDS Research, the Institute for Diabetes, Obesity, and Metabolism, the Mahoney Institute for Neurosciences, the Center for Orphan Disease Research and Therapy, the Institute for Translational Medicine and Therapeutics, the Penn Institute for Biomedical Informatics and the recently elevated Penn Epigenetics Institute.  The specific initiatives of these and other centers, institutes and departments are outlined within this website, along with our exceptional biomedical core facilities and research training programs.

I encourage you to explore our website and learn more about the many important and exciting scientific programs and resources available at the Perelman School of Medicine.

Jonathan A. Epstein, M.D.
Executive Vice Dean and Chief Scientific Officer